Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CIDD-0149897 |
Trade Name | |
Synonyms | |
Drug Descriptions |
CIDD-0149897 is a blood-brain barrier permeable ESR2 (ERbeta) agonist, which binds to ESR2 (ERbeta) and increases downstream target gene expression, potentially resulting in increased tumor cell apoptosis and decreased tumor growth (PMID: 37493258). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CIDD-0149897 | CIDD-0149897 | 0 | 0 |
CIDD-0149897 + Temozolomide | CIDD-0149897 Temozolomide | 0 | 0 |